{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:05:31Z","timestamp":1749614731265,"version":"3.41.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,10]]},"DOI":"10.7759\/cureus.85679","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:07:32Z","timestamp":1749546452000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Antimuscarinic Acetylcholine Receptor Antibody Titers With Pemphigus Disease Activity at Baseline and Following Phase I Pulse Therapy"],"prefix":"10.7759","author":[{"given":"Biswanath","family":"Behera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Palit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchanda","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya S","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusmita","family":"Sethy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris","volume":"8","author":"Mortazavi H","year":"2009","unstructured":"Mortazavi H, Shahdi M, Amirzargar AA, et al.. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris. Iran J Allergy Asthma Immunol. 2009, 8:53-6.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1666","article-title":"Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in pemphigus patients measured by area index and intensity score","volume":"94","author":"Patsatsi A","year":"2014","unstructured":"Patsatsi A, Kyriakou A, Giannakou A, Pavlitou-Tsiontsi A, Lambropoulos A, Sotiriadis D. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in pemphigus patients measured by area index and intensity score. Acta Derm Venereol. 2014, 94:203-6. 10.2340\/00015555-1666","journal-title":"Acta Derm Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02593.x","article-title":"Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris","volume":"45","author":"Sharma VK","year":"2006","unstructured":"Sharma VK, Prasad HR, Khandpur S, Kumar A. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Int J Dermatol. 2006, 45:518-22. 10.1111\/j.1365-4632.2006.02593.x","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10305","article-title":"Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions","volume":"106","author":"Nguyen VT","year":"2000","unstructured":"Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest. 2000, 106:1467-79. 10.1172\/JCI10305","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01190","article-title":"Non-desmoglein antibodies in patients with pemphigus vulgaris","volume":"9","author":"Amber KT","year":"2018","unstructured":"Amber KT, Valdebran M, Grando SA. Non-desmoglein antibodies in patients with pemphigus vulgaris. Front Immunol. 2018, 9:1190. 10.3389\/fimmu.2018.01190","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2004.00826.x","article-title":"New approaches to the treatment of pemphigus","volume":"9","author":"Grando SA","year":"2004","unstructured":"Grando SA. New approaches to the treatment of pemphigus. J Investig Dermatol Symp Proc. 2004, 9:84-91. 10.1111\/j.1087-0024.2004.00826.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106149","article-title":"Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+\/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris","volume":"80","author":"Chernyavsky A","year":"2020","unstructured":"Chernyavsky A, Patel KG, Grando SA. Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+\/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris. Int Immunopharmacol. 2020, 80:106149. 10.1016\/j.intimp.2019.106149","journal-title":"Int Immunopharmacol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.5070\/D36PV5W474","article-title":"Acetylcholine receptor antibodies in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up","volume":"18","author":"Tirado-S\u00e1nchez A","year":"2012","unstructured":"Tirado-S\u00e1nchez A, V\u00e1zquez-Gonz\u00e1lez D, Ponce-Olivera RM, L\u00f3pez-Lozano HE. Acetylcholine receptor antibodies in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Dermatol Online J. 2012, 18:14.","journal-title":"Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.039","article-title":"Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus","volume":"76","author":"Lakshmi MJ","year":"2017","unstructured":"Lakshmi MJ, Jaisankar TJ, Rajappa M, et al.. Correlation of antimuscarinic acetylcholine receptor antibody titers and antidesmoglein antibody titers with the severity of disease in patients with pemphigus. J Am Acad Dermatol. 2017, 76:895-902. 10.1016\/j.jaad.2016.11.039","journal-title":"J Am Acad Dermatol"},{"key":"ref10","article-title":"Pulse therapy and its modifications in pemphigus: a six year study","volume":"69","author":"Rao PN","year":"2003","unstructured":"Rao PN, Lakshmi TS. Pulse therapy and its modifications in pemphigus: a six year study. Indian J Dermatol Venereol Leprol. 2003, 69:329-33.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.48671","article-title":"Dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"75","author":"Manzoor S","year":"2009","unstructured":"Manzoor S, Bhat Y, Ahmad S. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Indian J Dermatol Venereol Leprol. 2009, 75:184-6. 10.4103\/0378-6323.48671","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_114_19","article-title":"Pulse therapy: opening new vistas in treatment of pemphigus","volume":"8","author":"Mustafi S","year":"2019","unstructured":"Mustafi S, Sinha R, Hore S, Sen S, Maity S, Ghosh P. Pulse therapy: opening new vistas in treatment of pemphigus. J Family Med Prim Care. 2019, 8:793-8. 10.4103\/jfmpc.jfmpc_114_19","journal-title":"J Family Med Prim Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.182428","article-title":"Pulse therapy in pemphigus: ready reckoner","volume":"61","author":"Abraham A","year":"2016","unstructured":"Abraham A, Roga G, Job AM. Pulse therapy in pemphigus: ready reckoner. Indian J Dermatol. 2016, 61:314-7. 10.4103\/0019-5154.182428","journal-title":"Indian J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell DF","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al.. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008, 58:1043-6. 10.1016\/j.jaad.2008.01.012","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.25780","article-title":"Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus","volume":"72","author":"Kumar B","year":"2006","unstructured":"Kumar B, Arora S, Kumaran MS, Jain R, Dogra S. Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus. Indian J Dermatol Venereol Leprol. 2006, 72:203-6. 10.4103\/0378-6323.25780","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03408.x","article-title":"Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity","volume":"24","author":"Hallaji Z","year":"2010","unstructured":"Hallaji Z, Mortazavi H, Lajevardi V, Tamizifar B, AmirZargar A, Daneshpazhooh M, Chams-Davatchi C. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. J Eur Acad Dermatol Venereol. 2010, 24:275-80. 10.1111\/j.1468-3083.2009.03408.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman KE","year":"2001","unstructured":"Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol. 2001, 144:775-80. 10.1046\/j.1365-2133.2001.04132.x","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.003","article-title":"Improving treatment outcome of pemphigus vulgaris on Vietnamese patients by using desmoglein elisa test","volume":"7","author":"Van AT","year":"2019","unstructured":"Van AT, Nguyen TV, Huu SN, et al.. Improving treatment outcome of pemphigus vulgaris on Vietnamese patients by using desmoglein elisa test. Open Access Maced J Med Sci. 2019, 7:195-7. 10.3889\/oamjms.2019.003","journal-title":"Open Access Maced J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14854","article-title":"Clinical and serological predictors of relapse in pemphigus: a study of 143 patients","volume":"47","author":"Genovese G","year":"2022","unstructured":"Genovese G, Maronese CA, Casazza G, et al.. Clinical and serological predictors of relapse in pemphigus: a study of 143 patients. Clin Exp Dermatol. 2022, 47:98-106. 10.1111\/ced.14854","journal-title":"Clin Exp Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2006.00410.x","article-title":"Cholinergic control of epidermal cohesion","volume":"15","author":"Grando SA","year":"2006","unstructured":"Grando SA. Cholinergic control of epidermal cohesion. Exp Dermatol. 2006, 15:265-82. 10.1111\/j.0906-6705.2006.00410.x","journal-title":"Exp Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12613582","article-title":"Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization","volume":"104","author":"Grando SA","year":"1995","unstructured":"Grando SA, Zelickson BD, Kist DA, et al.. Keratinocyte muscarinic acetylcholine receptors: immunolocalization and partial characterization. J Invest Dermatol. 1995, 104:95-100. 10.1111\/1523-1747.ep12613582","journal-title":"J Invest Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373944-correlation-of-antimuscarinic-acetylcholine-receptor-antibody-titers-with-pemphigus-disease-activity-at-baseline-and-following-phase-i-pulse-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:07:33Z","timestamp":1749546453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373944-correlation-of-antimuscarinic-acetylcholine-receptor-antibody-titers-with-pemphigus-disease-activity-at-baseline-and-following-phase-i-pulse-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.85679","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}